Patents by Inventor Niina Veitonmäki

Niina Veitonmäki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220213213
    Abstract: The invention provides bispecific polypeptides comprising a first binding domain, designated B1, which is capable of binding specifically to CD137, and a second binding domain, designated B2, which is capable of specifically binding to a tumour cell-associated antigen. Also provided are pharmaceutical compositions of such bispecific polypeptides and uses of the same in medicine.
    Type: Application
    Filed: September 23, 2021
    Publication date: July 7, 2022
    Inventors: Eva DAHLÉN, Peter ELLMARK, Christina FUREBRING, Per NORLÉN, Anna SÄLL, Laura von SCHANTZ, Niina VEITONMÄKI, Laura VARAS, Jessica PETERSSON, Sara FRITZELL
  • Publication number: 20190169308
    Abstract: The invention provides bispecific polypeptides comprising a first binding domain, designated B1, which is capable of binding specifically to CD137, and a second binding domain, designated B2, which is capable of specifically binding to a tumour cell-associated antigen. Also provided are pharmaceutical compositions of such bispecific polypeptides and uses of the same in medicine.
    Type: Application
    Filed: April 24, 2017
    Publication date: June 6, 2019
    Inventors: Eva Dahlén, Peter Ellmark, Christina Furebring, Per Norlén, Anna Säll, Laura von Schantz, Niina Veitonmäki, Laura Varas, Jessica Petersson, Sara Fritzell